Fig. 1
From: A Pronectin™ AXL-targeted first-in-class bispecific T cell engager (pAXLxCD3ε) for ovarian cancer
AXL receptor expression. A Representative FACS data of AXL binding on EOC cell lines. B Graphical representation of Antigen Bounding Count (ABC) evaluated on EOC cell lines by flow cytometry. C Representative immunofluorescence microscopy image of AXL (green) expression on the surface of EOC spheroids (red). D MFI (median fluorescence intensity) of AXL on ES-2 untreated cells and ES-2 platinum pre-treated cells compared to isotype control